<DOC>
	<DOCNO>NCT02733653</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness Jetstream Atherectomy System treatment Japanese patient symptomatic occlusive atherosclerotic lesion native superficial femoral artery ( SFA ) and/or proximal popliteal artery ( PPA ) .</brief_summary>
	<brief_title>Safety Effectiveness Jetstream Atherectomy System ( J-SUPREME )</brief_title>
	<detailed_description>A prospective , multicenter , single-arm trial evaluate safety efficacy Jetstream Atherectomy System treatment symptomatic occlusive atherosclerotic lesion ≤150 mm length locate femoropopliteal artery subject symptom classify Rutherford categories 2-4 .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Chronic , symptomatic low limb ischemia define Rutherford categories 24 Stenotic , restenotic occlusive lesion ( ) locate native SFA and/or PPA meet follow criterion : Calcified lesion degree stenosis ≥70 % occlusion Guidewire must cross lesion ( ) within true lumen , without subintimal course Vessel diameter ≥3.0 mm ≤6.0 mm Total lesion length ( series lesion ) ≤150mm Target lesion locate least 3 cm inferior edge femur visual estimate Patent infrapopliteal popliteal artery Target lesion/vessel instent restenosis Target lesion/vessel previously treat drugcoated balloon &lt; 12 month prior procedure Target lesion/vessel previously treat stent placement , atherectomy , laser debulking device prior procedure Subjects undergone surgery endovascular SFA/PPA target vessel treat atherosclerotic disease within 3 month prior index procedure Use drugcoated device , atherectomy , laser debulking device Jetstream System , chronic total occlusion ( CTO ) device cut balloon , Angioscore similar device target limb SFA/PPA index procedure History major amputation target limb Subject history coagulopathy hypercoagulable bleed disorder Subject untreatable hemorrhagic disease platelet count &lt; 80,000mm3 &gt; 600,000mm3 baseline assessment . Concomitant renal failure serum creatinine &gt; 2.0 mg/dL Receiving dialysis immunosuppressant therapy History myocardial infarction , stroke/cerebrovascular accident ( CVA ) within 6 month prior study enrollment Unstable angina pectoris time enrollment Septicemia time enrollment Presence hemodynamically significant outflow lesion target limb requiring plan surgical intervention endovascular procedure within 30 day index procedure Presence aneurysm target vessel Acute ischemia and/or acute thrombosis SFA/PPA prior index procedure Perforated vessel evidence extravasation contrast medium prior index procedure</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Superficial Femoral Artery</keyword>
	<keyword>Proximal Popliteal Artery</keyword>
	<keyword>Endovascular therapy</keyword>
	<keyword>Atherectomy</keyword>
</DOC>